BACKGROUND: Little is known concerning the impact of HIV status disclosure on quality of life, leaving clinicians and families to rely on research of children with other terminal illnesses. OBJECTIVES: The purpose of this work was to examine the impact of HIV disclosure on pediatric quality of life and to describe the distribution of age at disclosure in a perinatally infected pediatric population. METHODS. A longitudinal analysis was conducted of perinatally HIV-infected youth >/=5 years of age enrolled in a prospective cohort study, Pediatric AIDS Clinical Trials Group 219C, with >/=1 study visit before and after HIV disclosure. Age-specific quality-of-life instruments were completed by primary caregivers at routine study visits. The distribution of age at disclosure was summarized. Six quality-of-life domains were assessed, including general health perception, symptom distress, psychological status, health care utilization, physical functioning, and social/role functioning. For each domain, mixed-effects models were fit to estimate the effect of disclosure on quality of life. RESULTS: A total of 395 children with 2423 study visits were analyzed (1317 predisclosure visits and 1106 postdisclosure visits). The median age at disclosure was estimated to be 11 years. Older age at disclosure was associated with earlier year of birth. Mean domain scores were not significantly different at the last undisclosed visit compared with the first disclosed visit, with the exception of general health perception. When all of the visits were considered, 5 of 6 mean domain scores were lower after disclosure, although the differences were not significant. In mixed-effects models, disclosure did not significantly impact quality of life for any domain. CONCLUSIONS: Age at disclosure decreased significantly over time. There were no statistically significant differences between predisclosure and postdisclosure quality of life; therefore, disclosure should be encouraged at an appropriate time.
BACKGROUND: Little is known concerning the impact of HIV status disclosure on quality of life, leaving clinicians and families to rely on research of children with other terminal illnesses. OBJECTIVES: The purpose of this work was to examine the impact of HIV disclosure on pediatric quality of life and to describe the distribution of age at disclosure in a perinatally infected pediatric population. METHODS. A longitudinal analysis was conducted of perinatally HIV-infected youth >/=5 years of age enrolled in a prospective cohort study, Pediatric AIDS Clinical Trials Group 219C, with >/=1 study visit before and after HIV disclosure. Age-specific quality-of-life instruments were completed by primary caregivers at routine study visits. The distribution of age at disclosure was summarized. Six quality-of-life domains were assessed, including general health perception, symptom distress, psychological status, health care utilization, physical functioning, and social/role functioning. For each domain, mixed-effects models were fit to estimate the effect of disclosure on quality of life. RESULTS: A total of 395 children with 2423 study visits were analyzed (1317 predisclosure visits and 1106 postdisclosure visits). The median age at disclosure was estimated to be 11 years. Older age at disclosure was associated with earlier year of birth. Mean domain scores were not significantly different at the last undisclosed visit compared with the first disclosed visit, with the exception of general health perception. When all of the visits were considered, 5 of 6 mean domain scores were lower after disclosure, although the differences were not significant. In mixed-effects models, disclosure did not significantly impact quality of life for any domain. CONCLUSIONS: Age at disclosure decreased significantly over time. There were no statistically significant differences between predisclosure and postdisclosure quality of life; therefore, disclosure should be encouraged at an appropriate time.
Authors: David R Berk; Meira S Falkovitz-Halpern; David W Hill; Catherine Albin; Antonio Arrieta; Jane M Bork; Deborah Cohan; Bjorn Nilson; Ann Petru; Juan Ruiz; Peggy Sue Weintrub; Wanda Wenman; Yvonne A Maldonado Journal: JAMA Date: 2005-05-11 Impact factor: 56.272
Authors: Lois C Howland; Deborah S Storm; Sybil L Crawford; Yunsheng Ma; Steven L Gortmaker; James M Oleske Journal: J Assoc Nurses AIDS Care Date: 2007 Jan-Feb Impact factor: 1.354
Authors: Deborah S Storm; Mary G Boland; Steven L Gortmaker; Yan He; Joan Skurnick; Lois Howland; James M Oleske Journal: Pediatrics Date: 2005-01-03 Impact factor: 7.124
Authors: Kunjal Patel; Miguel A Hernán; Paige L Williams; John D Seeger; Kenneth McIntosh; Russell B Van Dyke; George R Seage Journal: Clin Infect Dis Date: 2008-02-15 Impact factor: 9.079
Authors: Alice Tseng; Michelle Foisy; Christine A Hughes; Deborah Kelly; Shanna Chan; Natalie Dayneka; Pierre Giguère; Niamh Higgins; Cara Hills-Nieminen; Jeff Kapler; Charles J L la Porte; Pam Nickel; Laura Park-Wyllie; Carlo Quaia; Linda Robinson; Nancy Sheehan; Shannon Stone; Linda Sulz; Deborah Yoong Journal: Can J Hosp Pharm Date: 2012-03
Authors: Gelane Workneh; Leah Scherzer; Brianna Kirk; Heather R Draper; Gabriel Anabwani; R Sebastian Wanless; Haruna Jibril; Neo Gaetsewe; Boitumelo Thuto; Michael A Tolle Journal: AIDS Care Date: 2012-04-26
Authors: A Bamford; A Turkova; H Lyall; C Foster; N Klein; D Bastiaans; D Burger; S Bernadi; K Butler; E Chiappini; P Clayden; M Della Negra; V Giacomet; C Giaquinto; D Gibb; L Galli; M Hainaut; M Koros; L Marques; E Nastouli; T Niehues; A Noguera-Julian; P Rojo; C Rudin; H J Scherpbier; G Tudor-Williams; S B Welch Journal: HIV Med Date: 2015-02-03 Impact factor: 3.180
Authors: V Boon-Yasidhi; T Naiwatanakul; K Chokephaibulkit; R Lolekha; P Leowsrisook; T Chotpitayasunond; M Wolfe Journal: Int J STD AIDS Date: 2015-03-30 Impact factor: 1.359
Authors: Suad Kapetanovic; Lisa Aaron; Paige L Williams; John Farley; Patricia A Sirois; Patricia A Garvie; Deborah A Pearson; James M Oleske; Grace Montepiedra Journal: Neurobehav HIV Med Date: 2010-08
Authors: Grace C John-Stewart; Grace Wariua; Kristin M Beima-Sofie; Barbra A Richardson; Carey Farquhar; Elizabeth Maleche-Obimbo; Dorothy Mbori-Ngacha; Dalton Wamalwa Journal: AIDS Care Date: 2012-12-20
Authors: Patricia A Sirois; Lisa Aaron; Grace Montepiedra; Deborah A Pearson; Suad Kapetanovic; Paige L Williams; Patricia A Garvie; Molly L Nozyce; Kathleen Malee; Sharon L Nichols; Betsy L Kammerer; Wendy G Mitchell; Mark Mintz; James M Oleske Journal: Pediatr Infect Dis J Date: 2016-01 Impact factor: 2.129